Dec 21, 2024 10:12 PM
BACK TO TOP
KSE100
109,513.14
3238.17
(3.05%)
ALLSHR
69,212.12
1727.86
(2.56%)
KSE30
34,513.39
1160.10
(3.48%)
KMI30
169,490.37
5959.15
(3.64%)
BKTI
23,721.66
751.62
(3.27%)
OGTI
29,513.18
842.03
(2.94%)
KMIALLSHR
48,342.31
1335.38
(2.84%)
PSXDIV20
41,786.73
1205.74
(2.97%)
UPP9
31,892.07
1097.34
(3.56%)
NITPGI
26,577.91
851.27
(3.31%)
NBPPGI
29,098.35
814.44
(2.88%)
MZNPI
22,447.28
730.80
(3.37%)
JSMFI
36,072.05
1001.96
(2.86%)
ACI
17,436.36
512.13
(3.03%)
JSGBKTI
26,919.59
900.50
(3.46%)
MII30
15,576.22
559.74
(3.73%)
HBLTTI
15,183.43
01-11-2024
8.25
(0.05%)
Otsuka Pakistan Limited
PHARMACEUTICALS
Rs.192.32
16.85
(9.60%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Fri, Dec 20, 2024 4:44 PM
REG
FUT
ODL
Open
166.55
High
193.02
Low
166.55
Volume
144,678
CIRCUIT BREAKER
157.92 — 193.02
DAY RANGE
166.55 — 193.02
52-WEEK RANGE
105.05 — 205.03
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
175.47
VAR
26.00
HAIRCUT
32.50
P/E Ratio (TTM) **
N/A
1-Year Change *
40.83%
YTD Change *
37.57%

No record found

No record found

Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

Otsuka Pakistan Limited was incorporated in Pakistan as a public limited company. The Company is engaged in the manufacturing, marketing, and distribution of intravenous infusions and trading in pharmaceutical products, nutritional foods, and medical equipment. The company is an indirect subsidiary of Otsuka Pharmaceutical Company Limited, Japan

KEY PEOPLE
Moin Ur RehmanCEO
Mikio BandoChairperson
Sajid Ali KhanCompany Secretary
ADDRESS

30 - B, Sindhi Muslim Co-Operative, Housing Society, Karachi

WEBSITE

www.otsuka.pk

REGISTRAR

THK Associates (Private) Limited, Plot No. 32-C, Jami Commercial Street 2, D.H.A, Phase-VII, Karachi

AUDITOR

M/s. Yousuf Adil Chartered Accountants

Fiscal Year End

June

Equity Profile

Market Cap (000's)
2,327,072.00
Shares
12,100,000
Free Float
2,970,872
Free Float
24.55%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Oct 30, 2024Transmission of Quarterly Accounts for the period ended September 30, 2024 View   PDF
Oct 30, 2024Financial Results for the Quarter Ended September 30, 2024 View   PDF
Oct 7, 2024Transmission of Annual Report for the Year Ended June 30, 2024 View   PDF
Aug 27, 2024Financial Results for the year ended June 30, 2024 View   PDF
Apr 25, 2024Financial Results for the Quarter Ended March 31, 2024 View   PDF
Feb 28, 2024Transmission of Half Yearly Accounts for the period ended December 31, 2023 View   PDF
Feb 20, 2024Financial Results for the Half Year ended December 31, 2023 View   PDF
Oct 30, 2023Transmission of Quarterly Report for the Period Ended September 30, 2023 View   PDF
Oct 30, 2023Financial Results for the Quarter Ended September 30, 2023 View   PDF
Sep 11, 2023Transmission of the Annual Report for the year ended June 30, 2023 View   PDF
DateTitleDocument
Oct 16, 2024Board of Directors Meeting View   PDF
Sep 26, 2024Notice of 36th Annual General Meeting of the Company View   PDF
Aug 15, 2024Board of Directors Meeting View   PDF
Apr 9, 2024Board of Directors Meeting View   PDF
Apr 9, 2024Emergent Board Meeting other than Financial Results View   PDF
Apr 1, 2024Emergent Board of Directors Meeting View   PDF
Mar 26, 2024Emergent Board Meeting other than financial results View   PDF
Mar 21, 2024Emergent Board of Directors Meeting Other Than Financial Results View   PDF
Feb 6, 2024Board of Directors' Meeting View   PDF
Dec 18, 2023CORRIGENDUM - EMERGENT BOARD MEETING OTHER THAN FINANCIAL RESULTS View   PDF
DateTitleDocument
Nov 4, 2024SECP Approval on our request of AGM on 30-Oct-2024 @ 10:30 AM (Explanation for Exceeding 120-Day Compliance by 2 Days) View   PDF
Nov 1, 2024Change of Management after Election of Directors held in 36th AGM View   PDF
Nov 1, 2024EXTRACTS FROM THE RESOLUTIONS PASSED IN 36TH AGM OF THE COMPANY View   PDF
Oct 24, 2024AGM on 30-Oct-2024 @ 10:30 AM (Explanation for Exceeding 120-Day Compliance by 2 Days) View   PDF
Oct 22, 2024Notice of Election of Directors View   PDF
Oct 15, 2024Corporate Briefing Session - 2024 View   PDF
Jun 3, 2024Change of Share Registrar/Transfer Agent of the Company View   PDF
Apr 30, 2024Transmission of Quarterly Report for the nine months ended March 31, 2024 View   PDF
Mar 12, 2024Disclosure of Mateials Information View   PDF
Mar 8, 2024Disclosure of Materail Information View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2024202320222021
Sales3,163,8683,035,0852,851,7332,546,276
Profit after Taxation(4,763)(7,207)231,797386,331
EPS(0.39)(0.60)19.1631.93
Q1 2025Q3 2024Q2 2024Q1 2024
Sales810,914566,398778,258795,416
Profit after Taxation(119,685)(14,582)2,07135,923
EPS(9.89)(1.21)0.172.97
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2024202320222021
Gross Profit Margin (%)18.2421.2232.4933.19
Net Profit Margin (%)(0.15)(0.24)8.1315.17
EPS Growth (%)35.00(103.13)(39.99)324.04
PEG(8.58)1.17(0.32)0.03

Payouts

DateFinancial ResultsDetailsBook Closure
August 24, 2023 3:21 PM30/06/2023(YR) 15%(F) (D) 26/09/2023 - 02/10/2023
September 6, 2022 2:47 PM30/06/2022(YR) 15%(F) (D) 21/10/2022 - 27/10/2022
August 31, 2021 2:40 PM30/06/2021(YR) 15%(F) (D) 21/10/2021 - 27/10/2021
August 28, 2018 12:35 PM30/06/2018(YR) 12% (D) 18/10/2018 - 24/10/2018
October 25, 2017 10:10 AM30/09/2017(IQ) 10% (B) 07/11/2017 - 13/11/2017
October 23, 2013 10:52 AM30/09/2013(IQ) 10%(I) (B) 07/11/2013 - 13/11/2013
October 17, 2012 11:26 AM30/09/2012(IQ) 10%(i) (D) 01/11/2012 - 07/11/2012
October 19, 2011 10:13 AM30/09/2011(IQ) 12.5%(i) (D) 01/11/2011 - 07/11/2011
October 14, 2010 10:09 AM30/09/2010(IQ) 15%(i) An Interim Dividend for the year ending June 30,2011. (D) 27/10/2010 - 02/11/2010
September 1, 2009 12:47 PM30/06/2OO9(YR) 15% (D) 08/10/2009 - 14/10/2009

Financial Reports